Episode Details

Back to Episodes

Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

Published 2 years, 3 months ago

Description

Dr. Rae Bacharach discusses the paper, "Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis".

Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2806000

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.